The death toll from the Ebola outbreak in the Democratic Republic of the Congo has now climbed to 600, with 1,759 confirmed cases reported by the country’s health authorities. Currently, 750 patients are in isolation or hospitalization, with a bed occupancy rate of 94 percent. The outbreak, caused by the Bundibugyo Ebola virus and declared on May 15, marks the country’s 17th Ebola outbreak, affecting 37 health zones in three provinces.
Response efforts are facing various challenges, including community resistance to post-mortem sampling, limited treatment capacity, gaps in contact tracing, and inadequate supplies. Insecurity and restricted access in areas affected by armed groups further complicate the situation. The outbreak was declared in mid-May, with ongoing concerns about insecurity, population movements, and incomplete contact tracing adding to the complexity of the response.
Ebola, a severe and often fatal disease, is transmitted to humans from wild animals and spreads through contact with infected bodily fluids. Symptoms include flu-like signs, fever, and potential organ failure. The Bundibugyo species of Ebola involved in this outbreak has no specific treatment or vaccine, although research is underway to test potential candidates. The outbreak’s challenging context includes a humanitarian crisis, a remote and densely populated area, insecurity, and significant population and trade movements.
Symptoms typically manifest 2 to 21 days post-exposure, encompassing fever, fatigue, muscle pain, headache, vomiting, diarrhea, abdominal pain, and bleeding in severe cases. The World Health Organization has classified this outbreak as a Public Health Emergency of International Concern.
